Dedicated to applied biomedical research and analytical innovation, this division focuses on the conceptualization, optimization, and validation of diagnostic and analytical platforms.

Our diagnostic services support the detection and quantification of clinically relevant biomarkers across diverse biological matrices. We emphasize analytical sensitivity, specificity, and performance consistency, aligning assay parameters with defined experimental objectives and regulatory expectations where applicable.

In assay development, we adopt a systematic approach that includes target identification, antibody or reagent selection, assay format design, calibration optimization, performance validation, and analytical troubleshooting. Whether developing colorimetric, fluorescence-based, or chemiluminescent platforms, our objective is to establish reproducible and scalable systems suitable for research, pre-clinical evaluation, or industrial application.

Through scientific rigor, methodological refinement, and application-oriented design, we ensure that each assay platform delivers measurable accuracy, reliability, and translational relevance.